From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Jimmy Wyman is running the Boston Marathon for his wife, who has a rare form of lung cancer, in support of Dana-Farber.

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

In Sharmila Tagore’s cancer case, early detection was the game changer. Her story serves as both a cautionary tale and a ...

Cancer Research scientists have developed a new cell-based model of lung squamous cell carcinoma (LUSC), a type of lung cancer, which has the potential to develop more effective treatments for the ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...

These targeted therapies confer the longest survival in non-small cell lung cancer and are better tolerated than cytotoxic agents. The use of ALK inhibitors in the clinic not only increases ...

The programme aims to enhance access to targeted cancer therapies by identifying actionable genetic mutations in lung cancer patients ...

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.